Recombinant Rhodopirellula baltica Tryptophan--tRNA ligase (trpS), also known as tryptophanyl-tRNA synthetase, is an enzyme that catalyzes the attachment of tryptophan to its corresponding tRNA molecule . This process is essential for protein biosynthesis, ensuring that tryptophan is correctly incorporated into polypeptide chains during translation . The recombinant form of this enzyme is produced in a host organism such as E. coli, yeast, baculovirus, or mammalian cells, and it has a purity greater than or equal to 85% as determined by SDS-PAGE .
The gene name for Tryptophan--tRNA ligase in Rhodopirellula baltica is trpS . It encodes for tryptophanyl-tRNA synthetase . The recombinant form of the enzyme is often produced with a tag, such as a 6His tag at the N-terminus, to facilitate purification .
Tryptophan--tRNA ligase (TrpRS) is a member of the aminoacyl-tRNA synthetases (aaRSs), which are responsible for the aminoacylation of tRNA molecules . The reaction involves two steps:
Tryptophan is activated by ATP to form tryptophanyl-AMP and pyrophosphate.
The activated tryptophan is transferred to the 3'-end of the tRNA molecule, releasing AMP.
This process ensures the correct insertion of tryptophan into proteins during translation.
Rhodopirellula baltica is a marine bacterium belonging to the Planctomycetes-Verrucomicrobia-Chlamydiae (PVC) superphylum . Phylogenetic analyses based on ribosomal proteins and RNA polymerase subunits suggest a relationship between Planctomycetes and Chlamydiae . Rhodopirellula baltica exhibits unique cellular features, including protein glycosylation and a complex cell structure .
Tryptophan biosynthesis involves a series of enzymatic reactions. Analysis of the Sargasso Sea metagenome reveals that tryptophan (trp) genes constitute a significant portion of amino acid biosynthesis genes . Many marine organisms may lack an operon-type organization of these genes or have mini-operons containing only two trp genes .
Recombinant Tryptophan--tRNA ligase is used in various biochemical and biophysical studies. These include:
Enzyme kinetics: Determining the efficiency and specificity of the enzyme.
Structural studies: Analyzing the 3D structure of the enzyme using X-ray crystallography or cryo-EM.
Inhibitor screening: Identifying compounds that can inhibit the enzyme's activity, which may have therapeutic potential.
Protein Engineering: Modifying the enzyme to enhance its activity, stability, or specificity.
KEGG: rba:RB6436
STRING: 243090.RB6436
What is Rhodopirellula baltica Tryptophan--tRNA ligase (trpS) and what is its biological function?
Rhodopirellula baltica Tryptophan--tRNA ligase (trpS), also known as tryptophanyl-tRNA synthetase (TrpRS), is an essential enzyme responsible for charging tRNATrp with L-tryptophan during protein synthesis. As a member of class I aminoacyl-tRNA synthetases (AARSs), it contains a Rossmann fold (RF) aminoacylation domain which is characteristic of its class . The biological function of this enzyme is indispensable for protein translation, as it ensures the correct incorporation of tryptophan into growing polypeptide chains.
R. baltica is a marine organism belonging to the Planctomycetes phylum, which exhibits unique cellular characteristics and is considered an important model organism for studying aerobic carbohydrate degradation in marine environments .
What are the key structural differences between bacterial and eukaryotic TrpRS?
Bacterial TrpRS, including that from R. baltica, differs significantly from eukaryotic TrpRS in both sequence and structural features, particularly at the active sites:
In bacterial TrpRS, the indole nitrogen of substrate L-Trp is coordinated by hydrogen bonding with an aspartate residue located in an α-helix .
In contrast, eukaryotic TrpRS forms this hydrogen bond using a tyrosine residue positioned in a β-strand .
This structural distinction is notable because other aminoacyl-tRNA synthetases typically show conservation of active site residues across evolutionary lineages. The difference in substrate recognition mechanisms suggests divergent evolutionary paths for TrpRS compared to other AARSs.
How does the expression of trpS change during R. baltica's growth cycle?
The expression of genes involved in tryptophan biosynthesis, including trpS, varies throughout R. baltica's growth cycle:
During the transition from exponential to stationary phase, R. baltica upregulates genes for phenylalanine, tyrosine, and tryptophan biosynthesis (including RB6822 and RB6147) .
This upregulation is particularly notable in the late stationary phase (240h), as shown in the differential gene expression analysis:
| Growth Phase Comparison | Total Regulated Genes | Genes Encoding Hypothetical Proteins |
|---|---|---|
| 62h vs. 44h | 149 (2%) | 84 (56%) |
| 82h vs. 62h | 90 (1%) | 40 (44%) |
| 96h vs. 82h | 235 (3%) | 139 (59%) |
| 240h vs. 82h | 863 (12%) | 499 (58%) |
The physiological significance of this upregulation is currently unknown but correlates with proteome data . This pattern suggests that tryptophan metabolism plays an important role during the stationary phase, possibly related to stress response or adaptation to nutrient limitation.
What are the typical specifications of commercially available recombinant R. baltica TrpS?
Commercially available recombinant R. baltica Tryptophan--tRNA ligase typically has the following specifications:
Purity: Greater than or equal to 85% as determined by SDS-PAGE
Expression systems: Can be produced in E. coli, yeast, baculovirus, or mammalian cell expression systems
Format: Available in both liquid and lyophilized forms
For comparative purposes, human TrpRS (WARS/WARS1) recombinant proteins are typically produced with a 6His tag at the N-terminus and express the full-length sequence (e.g., Met1-Gln471) .
What expression systems are most effective for producing recombinant R. baltica TrpS?
Based on commercial production practices and research protocols:
E. coli expression systems are most commonly used for bacterial proteins like R. baltica TrpS due to their cost-effectiveness and high yield .
When higher eukaryotic-like post-translational modifications are required, mammalian or insect cell expression systems may be preferred.
Methodology:
Clone the trpS gene into an appropriate expression vector containing a promoter compatible with your chosen expression system
Transform/transfect the construct into the host system
Induce protein expression (e.g., with IPTG for E. coli systems)
Harvest cells and lyse using sonication protocols similar to those described for T. immobilis: 20 × 10s at 60–70% amplitude with 20s pause
Perform initial centrifugation at 10,000 × g for 10 min at 4°C to remove debris
Follow with ultracentrifugation at 100,000 × g for 40 min at 4°C to separate membrane fractions if necessary
What purification strategies yield high purity recombinant R. baltica TrpS?
For optimal purification of recombinant R. baltica TrpS:
Affinity Chromatography: If the recombinant protein includes a His-tag, use Ni-NTA or IMAC chromatography as the initial purification step
Ion Exchange Chromatography: Follow with anion or cation exchange chromatography depending on the protein's isoelectric point
Size Exclusion Chromatography: As a final polishing step to remove aggregates and achieve >90% purity
Buffer optimization is critical - TrpRS is typically stable in Tris-based buffers (50 mM Tris, pH 7.5) with moderate salt concentration (100-150 mM NaCl) .
For detergent-solubilized preparations, follow protocols similar to those used for membrane proteins:
How can researchers validate the enzymatic activity of purified R. baltica TrpS?
Standard assays for validating TrpRS activity include:
Aminoacylation Assay:
Incubate purified enzyme with tRNATrp, ATP, and [14C]-labeled L-tryptophan
At various time points, precipitate the charged tRNA with TCA
Measure radioactivity in the precipitate to determine aminoacylation rate
ATP-PPi Exchange Assay:
Monitor the formation of the Trp-AMP intermediate by measuring ATP-[32P]PPi exchange
This assay specifically evaluates the first step of the aminoacylation reaction
Half-of-the-Sites Reactivity Assessment:
Based on research on bacterial TrpRS, evaluate differential binding of ATP to determine if R. baltica TrpRS exhibits the half-of-the-sites reactivity observed in other bacterial TrpRS enzymes
This phenomenon refers to the observation that once TrpAMP is formed in one subunit, the second subunit can no longer efficiently produce TrpAMP